<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01877174</url>
  </required_header>
  <id_info>
    <org_study_id>SRM-2013-01</org_study_id>
    <nct_id>NCT01877174</nct_id>
  </id_info>
  <brief_title>MICHI™ Neuroprotection System (NPS+f) Filter Debris Analysis Study (The F-1 Study)</brief_title>
  <official_title>MICHI™ Neuroprotection System (NPS+f) Filter Debris Analysis Study (The F-1 Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Silk Road Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Silk Road Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted in up to 10 hospitals in Europe, up to 75 patients will be
      enrolled. The purpose of the study is to evaluate any debris that may be captured in the
      inline filter of the MICHI(TM) Neuroprotection System with Filter (NPS+f) during its use in a
      transcarotid stenting procedure. The MICHI NPS+f is an embolic protection device that uses
      reverse flow to protect the brain during stenting of the Internal Carotid Artery. It is CE
      marked and is used in routine practice for the purpose of this study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with debris captured in the MICHI(TM) inline filter</measure>
    <time_frame>During MICHI(TM) NPS+f procedure</time_frame>
    <description>The percentage of patients with any debris captured in the MICHI(TM) inline filter will be calculated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of debris captured in the MICHI(TM) inline filter</measure>
    <time_frame>During MICHI(TM) NPS+f procedure</time_frame>
    <description>For all patients, where debris is captured in the MICHI(TM) inline filter, the volume of debris will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histological analysis of debris captured in the MICHI(TM) inline filter</measure>
    <time_frame>During MICHI(TM) NPS+f procedure</time_frame>
    <description>For all patients, where debris is captured in the MICHI(TM) inline filter, the type of plaque will be determined.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Internal Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>MICHI(TM) NPS+f</arm_group_label>
    <description>Patients routinely treated with the CE marked MICHI(TM) NPS+f System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MICHI(TM) NPS+f</intervention_name>
    <description>Transcarotid delivery system for carotid stents with flow reversal</description>
    <arm_group_label>MICHI(TM) NPS+f</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transcarotid stenting</intervention_name>
    <arm_group_label>MICHI(TM) NPS+f</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The inline filter of the MICHI(TM) NPS+f System may contain debris that is released from the
      lesion during carotid stenting. It is the objective of the study to determine the volume and
      characteristics of the debris.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are booked for a routine stenting of the Internal Carotid Artery (bifurcation
        may be involved) using the MICHI(TM) NPS+f System, at vascular surgery departments or
        interventional radiology departments
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion and exclusion criteria per CE marked Instructions For Use

        Inclusion Criteria:

          1. Adequate central venous access

          2. Common carotid artery reference diameter of at least 6 mm

          3. Carotid bifurcation is a minimum of 5 cm above the clavicle as measured by duplex
             Doppler ultrasound (DUS) or computerized axial tomography (CT) angiography or magnetic
             resonance (MR) angiography

        Exclusion Criteria:

          1. Patients in whom antiplatelet and/or anticoagulation therapy is contraindicated

          2. Patients with unresolved bleeding disorders

          3. Patients with severe disease of the ipsilateral common carotid artery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta Krankenhaus</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40472</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Son Espases</name>
      <address>
        <city>Palma</city>
        <state>Mallorca</state>
        <zip>07120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Medico Quirurgic</name>
      <address>
        <city>Jaen</city>
        <zip>23007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Toledo</name>
      <address>
        <city>Toledo</city>
        <zip>45004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2013</study_first_submitted>
  <study_first_submitted_qc>June 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2013</study_first_posted>
  <last_update_submitted>September 2, 2014</last_update_submitted>
  <last_update_submitted_qc>September 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Internal Carotid Stenosis</keyword>
  <keyword>Reverse Flow</keyword>
  <keyword>Carotid stenting</keyword>
  <keyword>MICHI(TM) NPS+f</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

